Articles dans des revues avec comité de lecture (253)
  1. 59. Karlócai, M. M., Tóth, K., Freund, T. T., Maglóczky, Z., Watanabe, M., Ledent, C., & Juhász, G. (2011). Redistribution of CB1 cannabinoid receptors in the acute and chronic phases of pilocarpine-induced epilepsy. PloS one, 6(11), e27196. doi:10.1371/journal.pone.0027196
  2. 60. Al-Hasani, R., Foster, J. D., Metaxas, A., Ledent, C., Hourani, S., Kitchen, I., & Chen, Y.-W. (2011). Increased desensitization of dopamine D₂ receptor-mediated response in the ventral tegmental area in the absence of adenosine A(2A) receptors. Neuroscience, 190, 103-111. doi:10.1016/j.neuroscience.2011.05.068
  3. 61. Köröskényi, K., Duró, E., Pallai, A., Sarang, Z., Kloor, D., Ucker, D. S., Beceiro, S., Castrillo, A., Chawla, A., Ledent, C., Fésüs, L., & Szondy, Z. (2011). Involvement of adenosine A2A receptors in engulfment-dependent apoptotic cell suppression of inflammation. The Journal of immunology, 186(12), 7144-7155. doi:10.4049/jimmunol.1002284
  4. 62. Mievis, S., Blum, D., & Ledent, C. (2011). Worsening of Huntington disease phenotype in CB1 receptor knockout mice. Neurobiology of disease, 42(3), 524-529. doi:10.1016/j.nbd.2011.03.006
  5. 63. Ruiz-Medina, J., Ledent, C., Carretón, O., & Valverde, O. (2011). The A2a adenosine receptor modulates the reinforcement efficacy and neurotoxicity of MDMA. Journal of psychopharmacology, 25(4), 550-564. doi:10.1177/0269881110389210
  6. 64. Pandolfo, P., Silveirinha, V., dos Santos-Rodrigues, A., Venance, L., Ledent, C., Takahashi, K., Cunha, R. A., & Köfalvi, A. (2011). Cannabinoids inhibit the synaptic uptake of adenosine and dopamine in the rat and mouse striatum. European journal of pharmacology, 655(1-3), 38-45. doi:10.1016/j.ejphar.2011.01.013
  7. 65. Mievis, S., Blum, D., & Ledent, C. (2011). A2A receptor knockout worsens survival and motor behaviour in a transgenic mouse model of Huntington's disease. Neurobiology of disease, 41(2), 570-576. doi:10.1016/j.nbd.2010.09.021
  8. 66. Ruiz-Medina, J., Ledent, C., & Valverde, O. (2011). GPR3 orphan receptor is involved in neuropathic pain after peripheral nerve injury and regulates morphine-induced antinociception. Neuropharmacology, 61(1-2), 43-50. doi:10.1016/j.neuropharm.2011.02.014
  9. 67. Thakur, S., Du, J., Hourani, S., Ledent, C., & Li, J.-M. (2010). Inactivation of adenosine A2A receptor attenuates basal and angiotensin II-induced ROS production by Nox2 in endothelial cells. The Journal of biological chemistry, 285(51), 40104-40113. doi:10.1074/jbc.M110.184606
  10. 68. Chioccarelli, T., Cacciola, G., Altucci, L., Lewis, S. E. M., Simon, L., Ricci, G., Ledent, C., Meccariello, R., Fasano, S., Pierantoni, R., & Cobellis, G. (2010). Cannabinoid receptor 1 influences chromatin remodeling in mouse spermatids by affecting content of transition protein 2 mRNA and histone displacement. Endocrinology, 151(10), 5017-5029. doi:10.1210/en.2010-0133
  11. 69. Urmaliya, V. V., Pouton, C. W., Short, J. L., White, P. J., & Ledent, C. (2010). Cooperative cardioprotection through adenosine A1 and A 2A receptor agonism in ischemia-reperfused isolated mouse heart. Journal of cardiovascular pharmacology, 56(4), 379-388. doi:10.1097/FJC.0b013e3181f03d05
  12. 70. Hussey, M., Clarke, G. D., Ledent, C., Kitchen, I., & Hourani, S. (2010). Genetic deletion of the adenosine A(2A) receptor in mice reduces the changes in spinal cord NMDA receptor binding and glucose uptake caused by a nociceptive stimulus. Neuroscience letters, 479(3), 297-301. doi:10.1016/j.neulet.2010.05.084
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 Suivant >>